Hebart H - Search Results

1

Fatal immune-mediated pancytopenia and a TRALI-like syndrome associated with high titers of recipient-type antibodies against donor-derived peripheral blood cells after allogeneic bone marrow transplantation following dose reduced conditioning.

Knop S, Bux J, Kroeber SM, Bader P, Hebart H, Kanz L, Einsele H. Knop S, et al. Among authors: hebart h. Haematologica. 2004 May 1;89(5):ECR12. Print 2004 May. Haematologica. 2004. PMID: 15136241

2

Cellular immunity to viral and fungal antigens after stem cell transplantation.

Einsele H, Hebart H. Einsele H, et al. Among authors: hebart h. Curr Opin Hematol. 2002 Nov;9(6):485-9. doi: 10.1097/00062752-200211000-00003. Curr Opin Hematol. 2002. PMID: 12394169 Review.

3

Follow-up of patients with progressive multiple myeloma undergoing allografts after reduced-intensity conditioning.

Einsele H, Schäfer HJ, Hebart H, Bader P, Meisner C, Plasswilm L, Liebisch P, Bamberg M, Faul C, Kanz L. Einsele H, et al. Among authors: hebart h. Br J Haematol. 2003 May;121(3):411-8. doi: 10.1046/j.1365-2141.2003.04299.x. Br J Haematol. 2003. PMID: 12716363 Free article.

4

Specific infectious complications after stem cell transplantation.

Hebart H, Einsele H. Hebart H, et al. Support Care Cancer. 2004 Feb;12(2):80-5. doi: 10.1007/s00520-003-0511-3. Epub 2003 Aug 15. Support Care Cancer. 2004. PMID: 12920624 Review.

5

Clinical aspects of CMV infection after stem cell transplantation.

Hebart H, Einsele H. Hebart H, et al. Hum Immunol. 2004 May;65(5):432-6. doi: 10.1016/j.humimm.2004.02.022. Hum Immunol. 2004. PMID: 15172442 Review.

6

Fludarabine may induce durable remission in patients with leptomeningeal involvement of chronic lymphocytic leukemia.

Knop S, Herrlinger U, Ernemann U, Kanz L, Hebart H. Knop S, et al. Among authors: hebart h. Leuk Lymphoma. 2005 Nov;46(11):1593-8. doi: 10.1080/10428190500178472. Leuk Lymphoma. 2005. PMID: 16236614

7

Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis.

Knop S, Engelhardt M, Liebisch P, Meisner C, Holler E, Metzner B, Peest D, Kaufmann M, Bunjes D, Straka C, Fischer T, Sezer O, Hentrich M, Ostermann H, Bassermann F, Hess G, Hertenstein B, Freund M, Kropff M, Schmidt CA, Wolf HH, Jung W, Frickhofen N, Mielke S, Bargou RC, Maschmeyer G, Svaldi M, Langer CH, Gramatzki M, Hebart H, Kanz L, Einsele H; Deutsche Studiengruppe Multiples Myelom. Knop S, et al. Among authors: hebart h. Leukemia. 2019 Nov;33(11):2710-2719. doi: 10.1038/s41375-019-0537-2. Epub 2019 Aug 28. Leukemia. 2019. PMID: 31462732 Clinical Trial.

8

Quantification of T-cell receptor excision circle DNA using fluorescence resonance energy transfer and the LightCycler system.

Loeffler J, Bauer R, Hebart H, Douek DC, Rauser G, Bader P, Einsele H. Loeffler J, et al. Among authors: hebart h. J Immunol Methods. 2002 Dec 20;271(1-2):167-75. doi: 10.1016/s0022-1759(02)00337-x. J Immunol Methods. 2002. PMID: 12445739

9

CMV-specific immunotherapy.

Einsele H, Hebart H. Einsele H, et al. Among authors: hebart h. Hum Immunol. 2004 May;65(5):558-64. doi: 10.1016/j.humimm.2004.02.003. Hum Immunol. 2004. PMID: 15172457 Review.

10

The efficacy and toxicity of bendamustine in recurrent multiple myeloma after high-dose chemotherapy.

Knop S, Straka C, Haen M, Schwedes R, Hebart H, Einsele H. Knop S, et al. Among authors: hebart h. Haematologica. 2005 Sep;90(9):1287-8. Haematologica. 2005. PMID: 16154860

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters